Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement in patients with trans-tricuspid valve pacemaker leads without ...
Early feasibility data from two studies of valve replacement presented at TCT 2021 show promise for novel transcatheter devices for mitral and tricuspid regurgitation. The Intrepid (Medtronic) ...
SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. For the TRISCEND trial, Susheel Kodali, MD, director of ...
The investigational transfemoral EVOQUE tricuspid valve replacement system (Edwards Lifesciences) significantly reduced severity of tricuspid regurgitation and improved quality of life at 30 days in ...
IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter ...
Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the successful completion of a Series C funding round worth $22 million. The ...
DUBLIN--(BUSINESS WIRE)--The "Tricuspid Valve Repair Market Size, Share & Trends Analysis Report By End-use (Ambulatory Surgical Centers, Hospitals), By Indication (Tricuspid Valve Regurgitation, ...
Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...
An international study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) and also have less than severe ...
Tricuspid Valve Repair Market Overview: The Global Tricuspid Valve Repair Market is expected to reach a US$2.5 billion market by 2028. Rise in the incidence of tricuspid valve disorders, advancements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results